Population pharmacokinetic model for a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients

被引：0
|
作者：
Parasrampuria, R. [1 ]
Easton, R. [1 ]
Yao, Z. [1 ]
Bensen-Kennedy, D. [1 ]
Voigt, C. [1 ]
Jacobs, I [1 ]
Massimo, M. [2 ]
机构：
[1] CSL Behring, King Of Prussia, PA USA
[2] Azienda Osped Univ Careggi, Florence, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：829 / 829
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetic (PK) results of two Phase III clinical studies of coagulation factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in previous treated patients with hemophilia B (PROLONG-9FP)
    Santagostino, Elena
    Jacobs, Iris
    Voigt, Christine
    Feussner, Annette
    Limsakun, Tharin
    Easton, Rachael
    HAEMOPHILIA, 2014, 20 : 15 - 15
  • [32] Efficacy, PK and safety results of a Phase I/II clinical study of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in previously treated patients with hemophilia B
    Martinowitz, U.
    Lubetsky, A.
    Santagostino, E.
    Jotov, G.
    Brutman-Barazani, T.
    Voigt, C.
    Moises, T.
    Jacobs, I
    Lissitchkov, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 240 - 241
  • [33] PROLONG-9FP clinical development program - phase I results of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP)
    Santagostino, Elena
    THROMBOSIS RESEARCH, 2013, 131 : S7 - S10
  • [34] Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children Results of a phase 3 trial
    Kenet, Gili
    Chambost, Herve
    Male, Christoph
    Lambert, Thierry
    Halimeh, Susan
    Chernova, Tatiana
    Mancuso, Maria Elisa
    Curtin, Julie
    Voigt, Christine
    Li, Yanyan
    Jacobs, Iris
    Santagostino, Elena
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (04) : 659 - 668
  • [35] Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children with Hemophilia B: Efficacy and Safety from a Phase 3 Pivotal Clinical Trial
    Kenet, G.
    Chambost, H.
    Male, C.
    Lambert, T.
    Alvarez-Roman, M-T
    Halimeh, S.
    Chan, A.
    Barnes, C.
    Chernova, T.
    Blatny, J.
    Mancuso, M. E.
    Meunier, S.
    Komrska, V.
    Laws, H-J
    Morfini, M.
    Curtin, J.
    Blazek, B.
    Voigt, C.
    Jacobs, I.
    Santagostino, E.
    HAEMOPHILIA, 2016, 22 : 22 - 23
  • [36] Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Adolescent and Adult Patients with Hemophilia B: Efficacy and Safety from a Phase 3 Pivotal Clinical Trial
    Santagostino, E.
    Martinowitz, U.
    Lissitchkov, T.
    Pan-Petesch, B.
    Hanabusa, H.
    Oldenburg, J.
    Boggio, L.
    Negrier, C.
    Pabinger, I.
    Prondzinski, M. Von Depka
    Altisent, C.
    Castaman, G.
    Yamamoto, K.
    Alvarez-Roman, M. -T.
    Voigt, C.
    Jacobs, I.
    HAEMOPHILIA, 2016, 22 : 61 - 62
  • [37] Efficacy, pharmacokinetics (PK) and safety results of a phase 3 clinical study of recombinant fusion protein linking coagulation factor IX with albumin (RIX-FP) in previously treated children with hemophilia B
    Kenet, G.
    Chambost, H.
    Male, C.
    Lambert, T.
    Alvarez-Roman, M.
    Halimeh, S.
    Chan, A.
    Barnes, C.
    Chernova, T.
    Blatny, J.
    Mancuso, M. E.
    Meunier, S.
    Komrska, V
    Laws, H-J
    Morfini, M.
    Curtain, J.
    Blazek, B.
    Voigt, C.
    Jacobs, I
    Santagostino, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 227 - 228
  • [38] Pharmacokinetic (PK) Results of Two Phase III Clinical Studies of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (RIX-FP) in Previous Treated Patients with Haemophilia B (PROLONG-9fp)
    Santagostino, E.
    Jacobs, I.
    Voigt, C.
    Feussner, A.
    Limsakun, T.
    HAEMOPHILIA, 2015, 21 : 27 - 28
  • [39] Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B
    Martinowitz, Uri
    Lubetsky, Aaron
    THROMBOSIS RESEARCH, 2013, 131 : S11 - S14
  • [40] Long-Term Safety and Efficacy of Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Previously Treated Pediatric Patients with Hemophilia B: Results from a Phase 3b Extension Study
    Kenet, Gili
    Chambost, Herve
    Male, Christoph
    Halimeh, Susan
    Lambert, Thierry
    Li, Yanyan
    Seifert, Wilfried
    Santagostino, Elena
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (04) : 599 - 606
12345